Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
AssigneePondera Biotechnologies, LLC
InventorsSteven Crain, William E. Crain, Stanley M. Crain, Michael Crain
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one Receptor Switcher and at least one Endorphin Enhancer. Additionally, at least one Synergistic Enhance and/or at least one Exogenous Opioid are also administered to enhance or prolong the therapeutic effects.
Claims41
A method to safely and effectively treat Distress Dysfunction conditions, symptoms and/or disorders in a subject in need comprising:
- (a) administering at least one Receptor Switcher to the subject;
- and
- (b) administering at least one compound to the subject selected from the group consisting of an Endorphin Enhancer, an Exogenous Opioid, a Synergistic Enhancer, and any combination thereof.
A method to enhance the therapeutic benefit and/or reduce the side effects of an ENDORPHIN ENHANCER, EXOGENOUS OPIOID, a SYNERGISTIC ENHANCER, or any combination thereof, in a subject comprising:
- (a) co-administering to a subject at least one RECEPTOR SWITCHER;
- or
- (b) co-administering to a subject at least one RECEPTOR SWITCHER combined with at least one ENDORPHIN ENHANCER and/or a SYNERGISTIC ENHANCER.
A composition useful in safely and effectively treating DISTRESS DYSFUNCTION comprising:
- (a) at least one RECEPTOR SWITCHER;
- and
- (b) at least one compound selected from the group consisting of an ENDORPHIN ENHANCER, an EXOGENOUS OPIOID, a SYNERGISTIC ENHANCER, and any combination thereof.
Dependencies are inferred from the claim text.